• Dr. John J Alapatt

    Consultant

Tab 1

Dr. John J Alapatt MBBS, DNB(Gen. Sur), MS, DrNB (Surgical Onco)

Consultant

Dr John J Alapatt is an accomplished surgical oncologist .He is currently a Consultant in Surgical Oncology at BMH Oncology Institute in Baby Memorial Hospital ,Kozhikode .Prior to this, he was a Consultant at MVRCCRI for the past 4 years.

Dr. Alapatt’s clinical interests include Peritoneal Surface Malignancy (CRS and HIPEC) ,Colorectal Oncology , Breast Oncoplasty and Minimally Invasive Cancer Surgery (Robotic and Laparoscopic) His passion for surgical oncology has led him to pursue advanced training in the field, including FEBS (European Board of Surgical Oncology)

Qualification

  • DrNB (Doctorate of the National Board of Examinations in Surgical Oncology) [2018 - 2021]
    from MCC – PGIOSR
  • MS (Mastery of Surgery), Kerala University of Health Sciences [2013 - 2016]
    from Amala Institute of Medical Sciences
  • DNB (Diplomate of National Board in General Surgery)
  • MBBS - Government Medical College, Kozhikode, University of Calicut [2005 – 2011]

Work Experience

  • Consultant: Department of Surgical Oncology, MVR Cancer Centre and Research Institute, Kozhikode, Kerala
  • Junior Resident: Division of Surgical Oncology, Jubilee Mission Medical College and Research Centre

Additional Qualifications

  • FACS (Fellow of the American College of Surgeons), 2025
  • F.E.B.S (Fellow of the European Board of Surgery in Surgical Oncology), Florence, Italy, 2023
  • MRCS (Member of the Royal College of Surgeons), Edinburgh
  • MNAMS (Member of the National Academy of Medical Sciences):
    Specialization in General Surgery and Surgical Oncology

Additional Training

  • Completed certification and training in Minimally Invasive Robotic Surgery using CMR and Da Vinci Robotic platforms

Research Publications

  • Relative Depth of Invasion (RDI) Index and clinicopathologic predictive factors for identifying high axillary nodal burden in ACOSOG Z0011–eligible breast cancer patients.
    JCO 43, e12585–e12585 (2025).
    DOI: 10.1200/JCO.2025.43.16_suppl.e12585
  • Moulding Breasts, Shaping Lives: Propagating Oncoplastic Surgery.
    Indian Journal of Surgical Oncology, August 2024.
    DOI: 10.1007/s13193-024-02071-0
  • Standardised Critical Care Strategies Improve Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in an Indian Peritoneal Malignancy Centre.
    Indian Journal of Surgical Oncology, August 2023, 14, 920–927.
    DOI: 10.1007/s13193-023-01803-y
  • Sentinel Lymph Node Biopsy by Lymphatic Flare Technique: A Feasibility Study – “The FLAIR Is in the FLARE”.
    Indian Journal of Surgical Oncology, December 2022; 13(4): 890–895.
    DOI: 10.1007/s13193-022-01574-y
  • Totally Implantable Venous Access Devices in Cancer Chemotherapy: A Retrospective Analysis of 8421 Catheter Days in a Tertiary Cancer Centre.
    Cancer Research, Statistics and Treatment, June 2021, Volume 4, Issue 3, Pg 449–455.
  • Wolf in Sheep’s Clothing: Metatarsal Osteosarcoma.
    The Sarcoma Journal, June 2019, 3(2): 13–18.
  • Unplanned Excision in Soft Tissue Sarcoma – Is It the Unkindest Cut of All?
    Cancer Research, Statistics and Treatment, July–December 2019, Volume 2, Issue 2, Pg 152–157.
  • Acute Necrotizing Pancreatitis After Esophagectomy: A Nail in the Coffin?
    Journal of Current Oncology, January 2019, Volume 2, Issue 2, Pg 84–88.
  • Patient Preference for Non-operative Treatment Strategy in Locally Advanced Rectal Cancers: A Cross-sectional Survey.
    Manuscript ID: IJSO-D-25-00067R1
  • An Audit of 1000 Breast Cancer Cases with Molecular Subtype Analysis from a Tertiary Care Cancer Centre in India.
    Manuscript ID: IJSO-D-24-00132R2
ummer
Dr. John J Alapatt

Consultant

OP DAYS AND TIMINGS
  • Mon 09:00 AM - 11:00 AM
  •   01:00 PM - 05:00 PM
  • Tue 09:00 AM - 11:00 AM
  •   01:00 PM - 05:00 PM
  • Wed 09:00 AM - 11:00 AM
  •   01:00 PM - 05:00 PM
  • Thu 09:00 AM - 11:00 AM
  •   01:00 PM - 05:00 PM
  • Fri 09:00 AM - 11:00 AM
  •   01:00 PM - 05:00 PM
  • Sat 09:00 AM - 11:00 PM
  •   01:00 PM - 05:00 PM
ummer
Dr. John J Alapatt
Consultant

Dr John J Alapatt is an accomplished surgical oncologist .He is currently a Consultant in Surgical Oncology at BMH Oncology Institute in Baby Memorial Hospital ,Kozhikode .Prior to this, he was a Consultant at MVRCCRI for the past 4 years.

Dr. Alapatt’s clinical interests include Peritoneal Surface Malignancy (CRS and HIPEC) ,Colorectal Oncology , Breast Oncoplasty and Minimally Invasive Cancer Surgery (Robotic and Laparoscopic) His passion for surgical oncology has led him to pursue advanced training in the field, including FEBS (European Board of Surgical Oncology)

  • DrNB (Doctorate of the National Board of Examinations in Surgical Oncology) [2018 - 2021]
    from MCC – PGIOSR
  • MS (Mastery of Surgery), Kerala University of Health Sciences [2013 - 2016]
    from Amala Institute of Medical Sciences
  • DNB (Diplomate of National Board in General Surgery)
  • MBBS - Government Medical College, Kozhikode, University of Calicut [2005 – 2011]
  • Consultant: Department of Surgical Oncology, MVR Cancer Centre and Research Institute, Kozhikode, Kerala
  • Junior Resident: Division of Surgical Oncology, Jubilee Mission Medical College and Research Centre
  • FACS (Fellow of the American College of Surgeons), 2025
  • F.E.B.S (Fellow of the European Board of Surgery in Surgical Oncology), Florence, Italy, 2023
  • MRCS (Member of the Royal College of Surgeons), Edinburgh
  • MNAMS (Member of the National Academy of Medical Sciences):
    Specialization in General Surgery and Surgical Oncology
  • Completed certification and training in Minimally Invasive Robotic Surgery using CMR and Da Vinci Robotic platforms
  • Relative Depth of Invasion (RDI) Index and clinicopathologic predictive factors for identifying high axillary nodal burden in ACOSOG Z0011–eligible breast cancer patients.
    JCO 43, e12585–e12585 (2025).
    DOI: 10.1200/JCO.2025.43.16_suppl.e12585
  • Moulding Breasts, Shaping Lives: Propagating Oncoplastic Surgery.
    Indian Journal of Surgical Oncology, August 2024.
    DOI: 10.1007/s13193-024-02071-0
  • Standardised Critical Care Strategies Improve Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in an Indian Peritoneal Malignancy Centre.
    Indian Journal of Surgical Oncology, August 2023, 14, 920–927.
    DOI: 10.1007/s13193-023-01803-y
  • Sentinel Lymph Node Biopsy by Lymphatic Flare Technique: A Feasibility Study – “The FLAIR Is in the FLARE”.
    Indian Journal of Surgical Oncology, December 2022; 13(4): 890–895.
    DOI: 10.1007/s13193-022-01574-y
  • Totally Implantable Venous Access Devices in Cancer Chemotherapy: A Retrospective Analysis of 8421 Catheter Days in a Tertiary Cancer Centre.
    Cancer Research, Statistics and Treatment, June 2021, Volume 4, Issue 3, Pg 449–455.
  • Wolf in Sheep’s Clothing: Metatarsal Osteosarcoma.
    The Sarcoma Journal, June 2019, 3(2): 13–18.
  • Unplanned Excision in Soft Tissue Sarcoma – Is It the Unkindest Cut of All?
    Cancer Research, Statistics and Treatment, July–December 2019, Volume 2, Issue 2, Pg 152–157.
  • Acute Necrotizing Pancreatitis After Esophagectomy: A Nail in the Coffin?
    Journal of Current Oncology, January 2019, Volume 2, Issue 2, Pg 84–88.
  • Patient Preference for Non-operative Treatment Strategy in Locally Advanced Rectal Cancers: A Cross-sectional Survey.
    Manuscript ID: IJSO-D-25-00067R1
  • An Audit of 1000 Breast Cancer Cases with Molecular Subtype Analysis from a Tertiary Care Cancer Centre in India.
    Manuscript ID: IJSO-D-24-00132R2
OP DAYS AND TIMINGS
  • Mon 09:00 AM - 11:00 AM
  •   01:00 PM - 05:00 PM
  • Tue 09:00 AM - 11:00 AM
  •   01:00 PM - 05:00 PM
  • Wed 09:00 AM - 11:00 AM
  •   01:00 PM - 05:00 PM
  • Thu 09:00 AM - 11:00 AM
  •   01:00 PM - 05:00 PM
  • Fri 09:00 AM - 11:00 AM
  •   01:00 PM - 05:00 PM
  • Sat 09:00 AM - 11:00 PM
  •   01:00 PM - 05:00 PM